TRANSPARENCY COUNCIL MEETING NO. 22/2023 JUNE 5, 2023
Opdivo (nivolumabum)
Indication: under drug program B.141 "Treatment of patients with urothelial carcinoma (ICD-10: C61, C65, C66, C67, C68)"
Decision-making problem: preparation of a position paper on the evaluation of the drug
Lonsurf (Trifluridinum + Tipiracilum) CONDITIONAL
Indication: under drug program B.58. "Treatment of patients with advanced esophageal and gastric cancer (ICD-10: C15-C16)"
Decision problem: preparing a position paper on the evaluation of the drug
Koselugo (selumetinibum)
Indication: under the drug program "Treatment of patients with plexiform neurofibromas in the course of neurofibromatosis type 1 (NF1) (ICD-10 : Q85.0)"
Decision-making problem: preparing a position paper on the evaluation of the drug
"Subsidy for infertility treatment by in vitro fertilization method for residents of Zduńska Wola County for 2024-2026"
"Support for infertility treatment by in vitro fertilization method - in vitro for residents of the Silesian province for 2023-2026"
"Health policy program for early detection of vision defects in children, especially myopia, including in connection with the implementation of remote learning during the COVID-19 epidemic"
Decision-making problem: Preparation of opinions on draft health policy programs of local government units
COUNCIL MEETING TRANSPARENCY NO. 23/2023 JUNE 12, 2023
Inclusion of the product emicizumab in the treatment of patients with hemophilia A, within the framework of module 4 of the health policy program entitled National Program for the Treatment of Patients with Hemophilia and Related Hemorrhagic Diathesis for 2019-2023
Decision-making problem: preparation of an opinion
In...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
